Abstract
Polyarteritis nodosa (PAN) is a necrotizing vasculitis of small- and medium-sized arteries with multiorgan involvement, rarely reported in childhood. Despite aggressive treatment with the combination of corticosteroids and cytotoxic agents, the overall prognosis is poor in most patients. We report on two siblings, now 15- and 14-year-old, affected with childhood onset PAN, refractory to multiple therapies, who showed rapid clinical and laboratory improvement when mycophenolate mofetil was introduced. The relationship between the administration of this immunosuppressant agent and the reduced disease activity is confirmed by the sustained absence of disease flares over 4 years of treatment.
This is a preview of subscription content, log in via an institution to check access.
References
Dillon MJ, Ozen S (2010) Polyarteritis nodosa and cutaneous polyarteritis in textbook of pediatric rheumatology, 6th edn. Elsevier Saunders, Amsterdam, pp 498–502
Ozen S, Bakkaloglu A, Dusunsel R, Soylemezoglu O, Ozaltin F, Poyrazoglu H, Turkish Pediatric Vasculitis Study Group et al (2007) Childhood vasculitis in Turkey: a nationwide survey. Clin Rheumatol 26:196–200
Ozen S, Anton J, Arisoy N, Bakkaloglu A, Besbas N, Brogan P et al (2004) Juvenile polyarteritis: results of a multicenter survey of 110 children. J Pediatr 145:517–522
Mason JC, Cowie MR, Davies KA, Schofield JB, Cambridge J, Jackson J et al (1994) Familial polyarteritis nodosa. Arthritis Rheum 37:1249–1253
Dillon MJ (2006) Vasculitis treatment-new therapeutic approach. Eur J Pediatr 165:351–357
Tullus K, Marks SD (2009) Vasculitis in children and adolescents: clinical presentation, etiopathogenesis, and treatment. Paediatr Drugs 11:375–380
Wright E, Dillon MJ, Tullus K (2007) Childhood vasculitis and plasma exchange. Eur J Pediatr 166:145–151
Iaccarino L, Rampudda M, Canova M, Della Libera S, Sarzi-Puttinic P, Doria A (2007) Mycophenolate mofetil: what is its place in the treatment of autoimmune rheumatic diseases? Autoimmun Rev 6:190–195
Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, Paediatric Rheumatology International Trials Organisation (PRINTO) et al (2010) EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis 69:798–806
Appenzeller S, Faria AV, Zanardi DA, Fernandes SR, Costallat LT, Cendes F (2008) Vascular involvement of the central nervous system and systemic diseases: etiologies an MRI findings. Rheumatol Int 28:1229–1237
Topaloglu R, Kazik M, Saatci I, Kalyoncu M, Cil BE, Akalan N (2005) An unusual presentation of classic polyarteritis nodosa in a child. Pediatr Nephrol 20:1011–1015
Kendirli T, Yüksel S, Oral M, Unal N, Tulunay M, Dilek US, Yalçnkaya F (2006) Fatal polyarteritis nodosa with gastrointestinal involvement in a child. Pediatr Emerg Care 22:810–812
Engel DG, Gospe SM Jr, Tracy KA, Ellis WG, Lie JT (1995) Fatal polyarterits nodosa with predominant central nervous system involvement. Stroke 26:699–701
Buonuomo PS, El Hachem M, Callea F, Bracaglia C, Diociaiuti A, Pardeo M, Campana A, Insalaco A, Cortis E, Ugazio AG (2010) Necrosis of the tongue as first symptom of Polyarteritis Nodosa (PAN): unusual presentation of a rare disease in children. Rheumatol Int [Epub ahead of print]
Feinstein J, Arroyo R (2005) Successful treatment of childhood onset refractory Polyarteritis nodosa with tumor necrosis factor alpha blockade. J Clin Rheumatol 11:219–222
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fernanda, F., Serena, C., Giustina, R. et al. Mycophenolate mofetil treatment in two children with severe polyarteritis nodosa refractory to immunosuppressant drugs. Rheumatol Int 32, 2215–2219 (2012). https://doi.org/10.1007/s00296-011-2003-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-011-2003-y